Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13226
Country/Region: Uganda
Year: 2013
Main Partner: Medical Access Uganda Limited
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $50,000,000

Medical Access Uganda Ltd is a local and indigenous not for profit organization engaged in Drug Supply & Logistics Management systems for HIV and other chronic illnesses drugs for national and donor funded projects. The overall goal of the Health Logistics Project is to provide HIV/AIDS-related commodities including ARVs to CDC funded HIV programs including faith based health facilities in Uganda; and to strengthen the capacity of institutions to manage HIV/AIDS logistics. Specifically, MAUL will collaborate with CDC, IPs, MOH and NDA to select health commodities and suppliers that meet National Treatment guidelines, the national formulary and PEPFAR guidelines to develop quantification plans and annual budgets. The specific objectives are: procurement of health commodities from approved suppliers in accordance with approved procurement plan & budget; establish safe and effective product storage systems; maintain good warehousing and stock management systems at all sites under this program; process of orders from health facilities and distribute the products in line with agreed delivery schedule, utilizing a reliable and cost effective distribution system; provide support to the design, acquisition and implementation of a harmonized national LMIS system to collect accurate, reliable and timely logistics data from health facilities; ensure that the Health Logistics Management Project is implemented effectively and efficiently in a way that fosters integration with other components of the health system and support the transition of the Health Logistics Management systems to the government of Uganda in a smooth and effective way, through local capacity building to ensure sustainability. Two vhicles will be purchases due to increased monitoring activities.

Funding for Treatment: ARV Drugs (HTXD): $50,000,000

The program targets to procure, store and supply ARVs for 114,544 patients currently on ART plus 52,337 New patients to be started on ART. The patients will be from all CDC-funded care and treatment implementing partners including TASO, UPMB, UEC, Baylor PIDC, IDI, SPH-Rakai, MJAP, Reach out Mbuya and Mildmay. MAUL has been and will continue to participate in the National quantification exercise with MOH, USAID and CDC. The organization managed an annual ARV procurement budget of about US$ 16.2 million for the CDC supported partners to treat approximately 90,000 patients on ART in over 118 sites across Uganda in FY2010.

Activities for FY 2012 include the following; Project process consolidation and expansion of the Project Management Team to enable an effective expansion process, selecting health commodities that meet PEPFAR and National Treatment guidelines, utilizing essential logistics & consumption data to forecast and quantify needs for each year, procure health commodities from approved suppliers in accordance with procurement plan, establish an effective storage network and maintain good warehousing practices, process all orders from health facilities and deliver them to site, support the implementation of a harmonized national LMIS system. These activities will be done in a manner that fosters integration of processes into the health system and sharing of information between all the implementing partners and the government for sustainability as well as ensuring that stronger health systems are built through human capital development. The project intends to align with all national processes and guidelines that have been established for the implementation of care and treatment of HIV patients. The procurement plan will be harmonized with the national quantification and procurement plan by the AIDS Control Program. All the implementing partners involved will be assisted in collaboration with treatment advisors to rationalize regimens and avoid requests for non-conforming products. As a measure of keeping with the national quality policy system, products on the NDA register will be procured at all times and an effort to get approval will be sought for those items that are not on the list but are required. MAUL will work towards strengthening existing systems for improved coordination, planning and M&E such as the implementation of a harmonized national LMIS. Training of staff at the 18 faith based health facilities will be done covering all the drug logistics functions like forecasting, stock management, warehousing and information management (LMIS).

Cross Cutting Budget Categories and Known Amounts Total: $1,400,000
Human Resources for Health $1,400,000